Inquiry launched on Monday 4 February 2019. The closing date for written submissions was Monday 18 March 2019 (Parliament UK)
Bibliography: Domestic Policy Issues
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
Cannabis policy and legislation in the Nordic countries
The Nordic Welfare Centre´s new report Cannabis policy and legislation in the Nordic countries looks at the similarities and differences in legislation and the ways in which the law is enacted in legal practice, police work, and other arenas
National Prison Drugs Strategy
Ministry of Justice and Her Majesty’s Prison and Probation Service Prison Drugs Strategy
Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971
This circular draws attention to the contents of the below Statutory Instruments (SIs), S.I. 2018/1356 and 2018/1383, which will come into force at 00.01 on 1 April 2019 (Home Office)
Supervised Drug Consumption Facilities Bill
1 Safe drug consumption facilities
2 Licence for provision of safe drug consumption facilities
3 Amendments to the Misuse of Drugs Act 1971
4 Annual report
5 Regulations
6 Financial provisions
7 Extent, commencement and short title
DrugScope Library Wellcome
This is a collection of grey literature and some archive material relating to drugs and drug policy, originally part of the library holdings at DrugScope (Wellcome)
Cannabis-based products for medicinal use in humans: commission to the ACMD
The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use
National Drug Control Strategy (PDF)
A Report by the Office of National Drug Control Policy
Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, it’s critical that we continue to address this tragedy from all fronts. This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose (FDA)
Review of the New Strategic Direction for Alcohol and Drugs – Phase 2
A report prepared for the Department of Health in Northern Ireland by the Institute of Public Health in Ireland (PDF)
State of the Nation 2018
The New Zealand Drug Foundation’s State of the Nation report is a snapshot of how New Zealand is dealing with alcohol and other drugs
Colorado publishes latest statistics on impact of cannabis legalisation
The state government instructed the state Department of Public Safety to report on key statistics of cannabis-related topics including crime, impaired driving, hospital visits, usage rates, effects on youth. A second biennial report was released in October 2018 (EMCDDA)
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States
Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member or close friend die from opioids. Increasing the availability and reducing the costs of approved medications for those with an opioid use disorder (OUD) is imperative; however, jurisdictions addressing OUDs and overdose may wish to consider additional interventions. Download (RAND)
He Ara Oranga : Report of the Government Inquiry into Mental Health and Addiction
The Inquiry Panel wanted to set a clear direction for the next five to ten years that Government, the mental health and addiction sectors and the whole community can pick up and make happen. Our purpose was to identify unmet needs and develop recommendations for a better mental health and addiction system for Aotearoa New Zealand
Guidance for drug and alcohol treatment providers and clients
Guidelines for drug and alcohol treatment providers on sharing client’s information with the National Drug and alcohol Treatment Monitoring System (NDTMS)
Review of the Psychoactive Substances Act 2016
This review sought to measure changes in outcomes before and after the implementation of the Act, to provide an indication of whether its aims are being achieved (Home Office)
Cannabis-based products for medicinal use: Guidance to clinicians
Following the Government’s announcement to reschedule certain cannabis-based products for medicinal use, NHS England has provided guidance to clinicians
Police powers and procedures, England and Wales, year ending 31 March 2018 (PDF)
This release contains statistics on the use of various police powers in England and Wales up to the year ending 31 March 2018 (Home Office)
Pregabalin and gabapentin to be controlled as class C drugs
New controls over prescription drugs pregabalin and gabapentin following rising fatalities (Home Office)
Rescheduling of cannabis-based products for medicinal use:Written statement
Today, the Government is laying the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 (“the 2018 Regulations”) in the House. These regulations reschedule cannabis-based products for medicinal use and will come into force on 1 November 2018 (Parliament, UK)
Alcohol, drugs and tobacco: commissioning support pack
Annual guidance on smoking, drinking and drug misuse for commissioners of tobacco control, drug and alcohol services for adults and young people (Public Health England)
Government’s response to the ACMD report on Medicinal cannabis
Eleven recommendations (Home Office)
5-Point Strategy To Combat the Opioid Crisis
HHS has a comprehensive strategy to empower local communities on the frontlines. The opioid epidemic is one of the Department’s top priorities. In 2017, HHS launched a 5-point Opioid Strategy
Further advice on scheduling of cannabis-derived medicinal products
Further advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products
Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder (PDF)
disorder in Canada should have access to comprehensive treatment options that meet all their needs. Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder presents services that should be available to individuals experiencing or at risk of experiencing harms from opioid use (CCSA)
Alcohol and Drug Strategy
On the 6 September 2018 the Scottish Government published its draft alcohol and drugs strategy document ‘All Together Now: our strategy to address the harms of alcohol and drugs in Scotland’ for engagement and to seek the views and feedback from partners and stakeholders in the sector
Drug health harms: national intelligence
Briefings based on presentations and discussion from the meeting of the national intelligence network on the health harms associated with drug use (Public Health England)
Crime, Drugs, and Power in Honduras: Searching for Better Measures of State Fragility (PDF)
This report argues that state ‘fragility’ metrics are inadequate. An increase in transparency and a call for new metrics are necessary to address entrenched elite corruption and organised crime in Honduras (GDPO)
South Africa’s National Drug Master Plan: Influenced & Ignored
The fourth South African National Drug Master Plan (2018-2022) is due for release in 2018 (GDPO)
The public health burden of alcohol: evidence review
This review looks at the impact of alcohol on the public health and the effectiveness of alcohol control policies (Public Health England)
Reducing Harm, Supporting Recovery 2017 – 2025
Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years (DoH Ireland)
Criminal Justice Project
Impact of Restriction on Bail on offenders who use Class A drugs in Liverpool (Public Health Institute)
Cannabis-derived medicinal products recommended to be available on prescription
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001
Advice on scheduling of cannabis-derived medicinal products
Advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products
What does the research evidence tell us about what Australians think about the legal status of drugs? A 2018 update
This bulletin summarises data from a nationally representative survey of Australians (The National Drug Strategy Household Survey) which asks people their opinions about the legal status of drug in 2016 (NDARC / DPMP)
Overlap between youth justice supervision and alcohol and other drug treatment services: 1 July 2012 to 30 June 2016
Compared with the age-equivalent Australian population, those who had youth justice supervision were 30 times as likely to have an alcohol and other drug treatment service, and those who received an alcohol and other drug treatment service were 30 times as likely to have youth justice supervision (AIHW)
Secure setting drug and alcohol treatment business definitions
Business definitions for secure setting drug and alcohol treatment providers to input data onto the national drug treatment monitoring system (NDTMS)
Drug health harms: national intelligence
Briefings based on presentations and discussion from the meeting of the national intelligence network on the health harms associated with drug use (Public Health England)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 11
- Next Page »
